LNCAROD and esophageal squamous cell carcinoma: We also observed that the deletion of LNCAROD in ESCC cells augmented irradiation‐induced DNA damage, G2/M phase arrest, and cell apoptosis, all of which were significantly mitigated by PARP1 overexpression.